Browsing Category
COVID-19
What are the Ingredients and Excipients in the COVID-19 Vaccines? Update including Novavax Vaccine
What's in a vaccine?
With the emergence of COVID-19, the crucial role that vaccines play in protecting our health has come into sharp focus. During this pandemic hope comes in the form of a vaccine and immunologists around the world are working to develop a vaccine that will protect us against…
Read More...
Read More...
mRNA vaccines — a new era in vaccinology
mRNA vaccines represent a promising alternative to conventional vaccine approaches because of their high potency, capacity for rapid development and potential for low-cost manufacture and safe administration. However, their application has until recently been restricted by the instability and…
Read More...
Read More...
Maintaining Safety with SARS-CoV-2 Vaccines
Review article by Mariana C. Castells, M.D., Ph.D., and Elizabeth J. Phillips, M.D. in The NEW ENGLAND JOURNAL of MEDICINE
To date, the development of mRNA vaccines for the prevention of infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a success story, with…
Read More...
Read More...
Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19
The present work aimed to develop an optimized liposomal formulation for enhancing the anti-viral activity of propolis against COVID-19. Docking studies were performed for certain components of Egyptian Propolis using Avigan, Hydroxychloroquine and Remdesivir as standard antivirals against both…
Read More...
Read More...
What are the Ingredients and Excipients in the COVID-19 Vaccines?
Covid-19 vaccination has been a big topic and we were curious on the role of excipients in such formulations. Not surprisingly both Pfizer-BioNTech and Moderna (source FDA) have quite similar compositions: Active Ingredient, Lipids and a saline solution. Lipid (oil) "bubbles" are tiny bubbles of…
Read More...
Read More...
Contract for innovative delivery system for COVID-19 vaccine
Press Release Croda
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. The person responsible for making this announcement is David Bishop, Director of Investor Relations.
Croda International Plc (“Croda” or “the Group”),…
Read More...
Read More...
Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible…
The SARS-Cov-2 pandemic that currently affects the entire world has been shown to be especially dangerous in the elderly (≥65 years) and in smokers, with notably strong comorbidity in patients already suffering from chronic diseases, such as Type 2 diabetes, cancers, chronic respiratory diseases,…
Read More...
Read More...
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
Remdesivir exhibits in vitro activity against SARS-CoV-2 and was granted approval for Emergency Use. To maximize delivery to the lungs, we formulated remdesivir as a dry powder for inhalation using thin film freezing (TFF). TFF produces brittle matrix nanostructured aggregates that are sheared into…
Read More...
Read More...
Propolis: the beehive’s immunitary system and the invisible mask
Since ancient times food supplements have been used to improve the health and the wellness, but
today of all days it is crucial to stay healthy and strong! The watchword is “equilibrium” to be ready, reinforcing the immune system and protecting the mucosae.
Our research has always been oriented…
Read More...
Read More...
The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at…
Inorganic polyphosphate (polyP) is a morphogenetically active and metabolic energy-delivering physiological polymer that is released from blood platelets. Here, we show that polyP efficiently inhibits the binding of the envelope spike (S)-protein of the coronavirus SARS-CoV-2, the causative agent of…
Read More...
Read More...